secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2022-06-22T23:59:59+00:00
Accession:  0001104659-22-073084
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA CMO resigns; Schlienger and Necina promoted effective July 1
--------------------------------------------------------------------

- CMO Igor Matushansky resigns effective June 30, 2022; will chair Scientific Advisory Board.
- Katia Schlienger promoted to EVP Clinical Development, joins Executive Team.
- Roman Necina appointed Chief Development Officer, integrating manufacturing and project management.
- Gilead registration rights agreement filed; Gilead may purchase up to $35M in common stock; initial $5M at $3.00/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922073084/0001104659-22-073084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922073084/tm2218404d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-073084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer